- decreased hematocrit / MGI
- abnormal erythropoiesis / MGI
- enlarged spleen / MGI
- anemia / MGI
- hemolytic anemia / MGI
- no abnormal phenotype detected / MGI
- abnormal erythrocyte morphology / MGI
- increased mean corpuscular volume / MGI
- reticulocytosis / MGI
- decreased hemoglobin content / MGI
- decreased erythrocyte cell number / MGI
- increased erythroid progenitor cell number / MGI
- abnormal erythrocyte osmotic lysis / MGI
- decreased susceptibility to parasitic infection / MGI
- increased circulating bilirubin level / MGI
- abnormal enzyme/coenzyme activity / MGI
- hemosiderosis / MGI
- abnormal common myeloid progenitor cell morphology / MGI
- increased nucleated erythrocyte cell number / MGI
- increased susceptibility to bacterial infection induced morbidity/mortality / MGI
- increased erythrocyte clearance / MGI
- decreased susceptibility to parasitic infection induced morbidity/mortality / MGI
- increased erythroblast number / MGI
C3El.Cg-PklrM1Neu/Ieg
| Status | Available to order |
| EMMA ID | EM:01946 |
| Citation information | RRID:IMSR_EM:01946 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C3El.Cg-PklrM1Neu/Ieg |
| Alternative name | PK10681 |
| Strain type | Induced Mutant Strains : Chemically-induced |
| Allele/Transgene symbol | PklrM1Neu |
| Gene/Transgene symbol | Pklr |
Information from provider
| Provider | Walter Pretsch |
| Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
| Genetic information | The mutation results in pyruvate kinase (Pk-1; pyruvate kinase liver and red blood cell, Pklr gene) hyperactivity. It is suggested that the regulatory locus of Pk-1 is affected by this mutation. |
| Phenotypic information | The PK activity alteration was detected in blood and could also be found in the liver but not in muscle, kidney, heart, spleen, lung, or brain. Heterozygous mice have erythrocyte PK activity enhanced up to about 160% and homozygotes up to about 240%, compared to homozygous wild-type mice. The heterozygous and homozygous mutants are viable and fully fertile and do not show symptoms of erythrocytosis. The mutation does not affect the heat stability, the electrophoretic mobility, or the Km (for phosphoenolpyruvate) of the PK protein. |
| Breeding history | C3H/El (7th generation) |
| References |
|
Information from EMMA
| Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Hemolytic anemia due to red cell pyruvate kinase deficiency / Orphanet_766
MGI phenotypes (gene matching)
Literature references
- Linear dose-response relationship of erythrocyte enzyme-activity mutations in offspring of ethylnitrosourea-treated mice.;Charles D J, Pretsch W, ;1987;Mutation research;176;81-91; 3796661
- The liver/erythrocyte pyruvate kinase gene complex [Pk-1] in the mouse: regulatory gene mutations.;Fitton L A, Davidson M, Moore K J, Charles D J, Pretsch W, Elston R C, Bulfield G, ;1991;Genetical research;58;233-41; 1802805
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
